Deposition of aerosols in infants and children

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 17, Issue 2, 2004, Pages 153-156

  Schüepp, Karen G ^a   Straub, Daniel ^a   Möller, Alexander ^a   Wildhaber, Johannes H ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Aerosol deposition; Childhood; Dry powder inhaler; Inhalation therapy; Nebulizer; Pressurized metered dose inhaler

Indexed keywords

BUDESONIDE;

BREATHING PATTERN; CONFERENCE PAPER; COOPERATION; DRUG CHOICE; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG FORMULATION; DRUG INDICATION; FUNCTIONAL ANATOMY; MEDICAL DECISION MAKING; MEDICAL NEBULIZER; PARTICLE SIZE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PEDIATRICS;

ADMINISTRATION, INHALATION; AEROSOLS; AGE FACTORS; ANTI-ASTHMATIC AGENTS; ASTHMA; BIOLOGICAL AVAILABILITY; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; EQUIPMENT DESIGN; EQUIPMENT SAFETY; FEMALE; HUMANS; INFANT; LUNG; MALE; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; RESPIRATORY THERAPY; RISK FACTORS;

EID: 3242694964     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/0894268041457228     Document Type: Conference Paper

References (22)

1. Janssens H.M., J.C. De Jongste, W.C. Hop, et al. 2003. Extra-fine particles improve lung delivery of inhaled steroids in infants. Chest 123:2083-2088.
2. Everard, M.L., A.R. Clark, and A.D. Milner. 1992. Drug delivery from jet nebulizers. Arch. Dis. Child. 67:586-591.
3. Chua, H.L., G.G. Collis, A.M. Newbury, et al. 1994. The influence of age in aerosol deposition in children with cystic fibrosis. Eur. Respir. J. 7:2185-2191.
4. Dolovich, M.A. 2000. Influence of inspiratory flow rate, particle size and airway caliber on aerosolized drug delivery to the lung. Respir. Care 45:597-608.
5. Everard, M.L., J.G. Hardy, and A.D. Milner. 1993. Comparison of nebulized aerosol deposition in the lungs of healthy adults following oral and nasal inhalation. Thorax 48:1045-1046.
6. Janssens, H.M., E.C. van der Weil, T.F.M. Verbraak, et al. 2003. Aerosol therapy and the fighting toddler: Is administration during sleep an alternative? J. Aerosol Med. 16:395-400.
7. Marks, M.K., M. South, and J.B. Carlin. 1993. Reference ranges for respiratory rate measured by thermistry (12-84 months). Arch. Dis. Child. 69:569-572.
8. Collis, G.G., C.H. Coler, and P.N. Souëf. 1990. Dilution of nebulized aerosols by air entrainment. Lancet 336:341-343.
9. Anhoi, J., L. Thorson, and H. Bisgaard. 2000. Lung deposition of inhaled drugs increases with age. Am. J. Respir. Crit. Care Med. 162:1819-1822.
10. Devadason, S.G., M.L. Everard, C. Macerlean, et al. 1997. Lung deposition from the Turbuhaler in children with cystic fibrosis. Eur. Respir. J. 10:2023-2028.
11. Wildhaber, J.H., N.D. Dore, J.M. Wilson, et al. 1999. Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children. J. Pediatr. 135:28-33.
12. Wildhaber, J.H., H.M. Janssens, F. Piérart, et al. 2000. High-percentage lung delivery in children from detergent-treated spacers. Pediatr. Pulmonol. 29:389-393.
13. Diot, P., L.B. Palmer, A. Smaldone, et al. 1997. RhDNase I aerosol deposition and related factors in cystic fibrosis. Am. J. Respir. Crit. Care Med. 156:1662-1668.
14. Wildhaber, J.H., S.G. Devadason, M.J. Hayden, et al. 1997. Aerosol delivery to wheezy infants: a comparison between a nebulizer and two small volume spacers. Pediatr. Pulmonol. 23:212-216.
15. Becquemin, M.H., D.L. Swift, A. Bouchikhi, et al. 1991. Particle deposition and resistance in the noses of adults and children. Eur. Respir. J. 4:694-702.
16. Geller, D.E., H. Eigen, S.F. Fiel, et al. 1998. Effect of smaller droplet size of Dornase Alfa on lung function in mild cystis fibrosis. Pediatr. Pulmonol. 25:83-87.
17. Mallol, J., S. Rattray, G. Walker, et al. 1996. Aerosol deposition in Infants with cystic fibrosis. Pediatr. Pulmonol. 21:276-281.
18. Newman, S.P. 1983. Therapeutic aerosols 1-Physical and practical considerations. Thorax 38:881s-886s.
19. Wildhaber, J.H., S.G. Devadason, J.M. Wilson, et al. 1998. Lung deposition of budesonide from Turbuhaler in asthmatic children. Eur. J. Pediatr. 157:1017-1022.
20. Devadason, S.G., T. Huang, S. Walker, et al. 2003. Distribution of technetium-99m-labellled QVAR™ delivered using an Autohaler™ device in children. Eur. Respir. J. 21:1007-1011.
21. Wildhaber, J.H. 2001. Inhalation therapy in children. In G. Scheuch, ed. Aerosols in Inhalation Therapy. Dustri, München-Deisenhofen, 52-57.
22. Keller, M., J. Jauernig, F.C. Lintz, et al. 2002. Nebulizer nanosuspensions: important device and formulation interactions. In R.N. Dalby, P.R. Byron, S.J. Farr, eds. Respiratory Drug Delivery VIII. Interpharm Press, Buffalo Grove, IL, 197-206.